#
Soliqua 100/33
  • Treatments
  • Diabetes
  • Type 2
  • Soliqua 100/33 (Subcutaneous)

Soliqua 100/33 (Subcutaneous)

Generic name:insulin glargine and lixisenatide (subcutaneous route) [ IN-su-lin-GLAR-jeen, ree-KOM-bi-nant, lix-i-SEN-a-tide ]
Drug class:Antidiabetic combinations

Medically reviewed by Drugs.com. Last updated on Jun 2, 2022.

Commonly used brand name(s)

In the U.S.

  • Soliqua 100/33

Available Dosage Forms:

  • Solution

Therapeutic Class: Antidiabetic

Pharmacologic Class: Insulin, Long Acting

Uses for Soliqua 100/33

Insulin glargine and lixisenatide combination is used to treat a type of diabetes mellitus (sugar diabetes) called type 2 diabetes.

Insulin glargine is a long-acting type of insulin that works slowly, over about 24 hours. Insulin is one of many hormones that help the body turn the food we eat into energy. This is done by using the glucose (sugar) in the blood as quick energy. Also, insulin helps us store energy that we can use later. When you have diabetes mellitus, your body cannot make enough insulin or does not use insulin properly. This causes you to have too much sugar in your blood. Like other types of insulin, insulin glargine is used to keep your blood sugar level close to normal. Lixisenatide is to be used when diet and exercise do not result in good blood sugar control.

This medicine is available only with your doctor's prescription.

Before using Soliqua 100/33

In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered:

Allergies

Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.

Pediatric

Appropriate studies have not been performed on the relationship of age to the effects of...